Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
included in hemorrhagic fevers |
|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
(Rubeola), all presentations |
Until 4 days after onset of rash; duration of illness in immune compromised |
Immediately contact HEIP. Susceptible heatlhcare personnel (HCP) should not enter room if immune HCP are available, regardless of presumptive evidence of immunity. HCP should use respiratory protection that is at least as protective as a fit-tested N95 respirator upon entry into the care area. Additional resources, including for testing, are available on the measles web page. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
(Burkholderia (Pseudomonas) pseudomallei) |
Notify the Microbiology laboratory when submitting specimens for culture from patients known or suspected to have this disease (353-1268) |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Aseptic (non-bacterial or viral [except varicella zoster*] meningitis; also see enterovirus) | |||
Bacterial, gram negative enteric, in neonates | |||
Fungal** |
**Alert the Microbiology Laboratory (353-1268) prior to submitting specimens for culture from patients with suspected or confirmed Coccidiodes meningitis |
||
Haemophilus influenzae (known or suspected) |
Until 24 hrs after initiation of effective therapy |
||
Listeria monocytogenes | |||
Neisseria meningitidis (known or suspected) |
Until 24 hrs after initiation of effective therapy |
||
Pneumococcal (Streptococcus pneumoniae) | |||
Tuberculosis*** |
***Patient should be examined for evidence of current (active) pulmonary tuberculosis. If evidence exists, see Tuberculosis below for additional isolations. |
||
Other diagnosed bacterial | |||
Varicella, disseminated (e.g., meningitis + rash) | |||
Unknown etiology |
Until etiology is determined or Neisseria meningitidis is ruled out |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Adult and Pediatric hematology/oncology/BMT patients: All other patients: Duration of illness |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Please continue isolation until the case is discussed with Infection Prevention. Isolation will be needed until lesions have crusted, those crusts have separated, and a fresh layer of healthy skin has formed underneath. |
Immediately contact HEIP. Refer to the UCSF Mpox Tip Sheet. Additional resources, including for testing, are available on the Mpox web page. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Enterococcus, vancomycin resistant (VRE) |
If drainage cannot be contained by dressing, add Contact + Standard Isolation |
||
Staphylococcus aureus, nafcillin / methicillin resistant | |||
Staphylococcus aureus, vancomycin intermediate/resistant |
Duration of hospitalization and upon readmission. |
Discontinuation will be determined by Infection Prevention on a case by case basis. |
|
Carbapenem Resistant Acinetobacter- carbapenemase gene positive |
Duration of hospitalization and upon readmission. |
Isolation may not be removed. The following carbapenemase genes are tested: KPC, NDM, OXA-48, VIM, IMP-1. |
|
Carbapenem, cefepime or ceftazidime resistant Pseudomonas aeruginosa- carbapenemase gene positive |
Duration of hospitalization and upon readmission. |
Isolation may not be removed. The following carbapenemase genes are tested: KPC, NDM, OXA-48, VIM, IMP-1. |